Penumbra Inc

PEN.US
Healthcare · Medical Devices
319.99
+0.50 (+0.16%)
USD · NYSE

Company Information

Company Name
Penumbra Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
ISIN: US70975L1070
CIK: 0001321732
CUSIP: 70975L107
Currency: USD
Full Time Employees: 4,700
Phone: 510 748 3200
Fiscal Year End: December
IPO Date: Sep 18, 2015
Description:

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Address:

One Penumbra Place, Alameda, CA, United States, 94502

People

Directors & Officers

Name Title Year Born
Mr. Adam Elsesser J.D. Co-Founder, Chairman & CEO 1962
Ms. Shruthi Narayan President 1985
Dr. Arani Bose M.D. Co-Founder & Director 1962
Ms. Maggie S. Yuen Chief Financial Officer 1972
Mr. Lambert Shiu Chief Accounting Officer 1980
Ms. Johanna Roberts J.D. Executive VP, General Counsel & Secretary 1972
Mr. Ben Sorci Executive Vice President of Operations NA
Mr. Pankaj Tiwari Executive VP & Chief Information Officer NA
Ms. Jee Hamlyn-Harris Investor Relations Officer NA
Mr. Ben Tompkins Executive Vice President of Development & Compliance NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 02, 2026 Harpreet Grewal N/A Sale 100.00 $328.22 $32.82K
Mar 02, 2026 Maggie Yuen N/A Sale 2.43K $342.30 $832.47K
Jan 06, 2026 Harpreet Grewal N/A Sale 186.00 $312.64 $58.15K
Jan 02, 2026 Thomas Wilder N/A Sale 186.00 $310.72 $57.79K
Dec 11, 2025 Arani Bose N/A Sale 15.00K $308.82 $4.63M
Dec 05, 2025 Johanna Roberts N/A Sale 300.00 $300.13 $90.04K
Dec 02, 2025 Harpreet Grewal N/A Sale 100.00 $292.98 $29.30K
Dec 01, 2025 Johanna Roberts N/A Sale 600.00 $294.94 $176.96K
Nov 25, 2025 Arani Bose N/A Sale 7.50K $300.19 $2.25M
Nov 25, 2025 Johanna Roberts N/A Sale 1.80K $300.06 $540.11K
Nov 21, 2025 Arani Bose N/A Sale 7.50K $290.56 $2.18M
Nov 10, 2025 Johanna Roberts N/A Sale 600.00 $266.98 $160.19K
Nov 04, 2025 Harpreet Grewal N/A Sale 186.00 $227.58 $42.33K
Nov 04, 2025 Harpreet Grewal N/A Sale 186.00 $227.58 $42.33K
Oct 02, 2025 Harpreet Grewal N/A Sale 186.00 $248.61 $46.24K
Oct 01, 2025 Johanna Roberts N/A Sale 600.00 $249.70 $149.82K
Oct 01, 2025 Thomas Wilder N/A Sale 186.00 $253.93 $47.23K
Sep 03, 2025 Adam Elsesser N/A Sale 15.80K $269.65 $4.26M
Sep 02, 2025 Harpreet Grewal N/A Sale 186.00 $272.19 $50.63K
Sep 02, 2025 Johanna Roberts N/A Sale 600.00 $270.58 $162.35K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.33M Mar 31, 2026 11.01% $0.02 4.57%
Vanguard Group Inc 3.77M Dec 31, 2025 9.59% $0.02 -1.69%
Vanguard Capital Management, LLC 1.69M Mar 31, 2026 4.31% $0.01 0.00%
Vanguard Portfolio Management, LLC 1.65M Mar 31, 2026 4.21% $0.03 0.00%
HBK INVESTMENTS L P 1.63M Mar 31, 2026 4.16% $5.45 0.00%
State Street Corp 1.19M Mar 31, 2026 3.01% $0.01 2.45%
Millennium Management LLC 1.10M Mar 31, 2026 2.79% $0.15 62.01%
Baillie Gifford & Co Limited. 840.43K Mar 31, 2026 2.14% $0.28 -4.10%
Geode Capital Management, LLC 795.45K Mar 31, 2026 2.02% $0.02 3.78%
Balyasny Asset Management LLC 762.10K Mar 31, 2026 1.94% $0.32 370.69%
The Goldman Sachs Group Inc 720.58K Mar 31, 2026 1.83% $0.03 126.49%
Citigroup Inc 620.94K Mar 31, 2026 1.58% $0.09 1,203.13%
UBS Group AG 560.34K Mar 31, 2026 1.42% $0.03 272.63%
Amvescap Plc. 538.20K Mar 31, 2026 1.37% $0.02 -15.68%
FMR Inc 496.11K Mar 31, 2026 1.26% $0.01 -90.33%
Champlain Investment Partners, LLC 491.38K Mar 31, 2026 1.25% $2.05 -18.35%
ExodusPoint Capital Management, LP 465.22K Mar 31, 2026 1.18% $1.21 2,038.92%
Capital World Investors 450.82K Mar 31, 2026 1.15% $0.02 5.71%
Whitebox Advisors, LLC 445.00K Mar 31, 2026 1.13% $1.80 0.00%
Cnh Partners, LLC 423.07K Mar 31, 2026 1.08% $2.28 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 1.34M 3.40% ▼ 0.54% Jun 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.19M 3.02% ▲ 0.03% Jun 30, 2026
3 Vanguard Small Cap Index 856.80K 2.18% ▼ 0.12% Jun 30, 2026
4 BlackRock Event Driven Equity Instl 769.79K 1.96% ▲ 0.00% Jun 30, 2026
5 Vanguard US Growth Investor 502.94K 1.28% ▲ 0.00% Mar 31, 2026
6 Vanguard Small Cap Growth Index Inv 495.12K 1.26% ▲ 2.57% Jun 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 451.36K 1.15% ▲ 1.77% Jun 30, 2026
8 American Funds SMALLCAP World A 412.64K 1.05% ▲ 0.00% Jun 30, 2026
9 State Street® SPDR® S&P MIDCAP 400® ETF 302.61K 0.77% ▲ 2.96% Jun 30, 2026
10 iShares S&P Mid-Cap 400 Growth ETF 233.87K 0.59% ▼ 0.60% Jun 30, 2026

Financial Highlights

Market Cap: $12.57B
EBITDA: $203.96M
P/E Ratio: $73.45
PEG Ratio: $4.08
Book Value: $37.48
Earnings/Share: $4.35
Profit Margin: 11.76%
Operating Margin: 10.20%
ROA (TTM): 6.70%
ROE (TTM): 12.73%
Revenue (TTM): $1.45B
Revenue/Share (TTM): $37.20
Earnings Growth (YOY): -18.00%
Revenue Growth (YOY): 15.60%

Valuation Metrics

Enterprise Value: $12.14B
Trailing P/E: 73.45
Forward P/E: 63.29

Shares Statistics

Shares Outstanding: 39.33M
Shares Float: 38.23M
% Insiders: 289.80%
% Institutions: 8,712.60%
Short % Float: 6.21%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.40B
Cost of Goods Sold
adjust
$-461.23M
Gross Profit
subtotal
$942.44M
SG&A
adjust
$-663.42M
R&D
adjust
$-89.77M
Operating Income
subtotal
$189.25M
Other / Non-Operating Items
adjust
$-11.56M
Net Income
subtotal
$177.69M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PEN.US!